TNF inhibitor
Date |
Type | Title | Save |
|---|---|---|---|
| 09 Apr 2018 | News | Favorable Certolizumab Safety Profile in Pregnancy | |
| 05 Mar 2018 | News | Severe Stevens-Johnson and Toxic Epidermal Necrolysis Syndromes May Respond to Etanercept | |
| 20 Feb 2018 | News | Pediatric Use of TNF inhbitors Does Not Increase Malignancy Risk | |
| 20 Feb 2018 | Social | PANTS study:Personalized anti-TNF Therapy in Crohn Disease tests real-world eficacy, safety & immunogenicity of infliximab vs biosimilar CT- P13 vs adalimumab. Wk 54 remission rate was 40% INFX, 40% CTP13 & 34% in ADA; immunogenicity was 26%, 28%, 11% https://t.co/irhImH6ipP | |
| 12 Feb 2018 | Social | RT @uptoTate: Obesity as a predictor for poor TNFi response in IBD. Dr. U. Mahadevan #RWCS @RheumNow https://t.co/nmCljYcaqJ | |
| 10 Feb 2018 | Social | RT @uptoTate: Likelihood of achieving remission in patients who’ve failed one TNFi. Dr. M. Genovese #RWCS @RheumNow https://t.co/kFt0InT5q5 | |
| 26 Jan 2018 | Social | RheumNow Wk in Review is up. Discussing MPO bronchiectasis, $$ biologics, comorbidity in myositis, secondary TNF failure & ADAbs. Listen here https://t.co/wmVyjrzOB1 Watch there https://t.co/32q2qojDZC | |
| 25 Jan 2018 | News | Obesity Outweighs Psoriasis in Comorbidity Risk with Children | |
| 25 Jan 2018 | News | Anti-Drug Antibodies Partly Explain Secondary TNF Inhibitor Failures | |
| 24 Jan 2018 | News | PRESERVE Study: HAQ, BMI and Age Predict Responses to Combo Therapy | |
| 12 Jan 2018 | Social | 188 PsA pts receive 1st TNFi, 27% D/C by 24 mos (1/3 for primary inefficacy, 22% secondary inefficacy, 43% adverse events) Predictors of failure = female or metabolic syndrome-co-morbidities (HR = 2.65). https://t.co/VRdikUSQ0f | |
| 08 Dec 2017 | News | Why TNF Inhibitors May Work in Some Autoinflammatory Patients | |
| 07 Dec 2017 | News | Infliximab Does Not Increase Perioperative Infection | |
| 21 Nov 2017 | ACR Video | Dr. Rachel Tate: Sarcoidosis and TNF Inhibitors | |
| 08 Nov 2017 | Social | RT @uptoTate: 84% of cardiac sarcoidosis pts refractory to immunosuppressive tx responded to TNFi. #ACR17 @RheumNow #2904 https://t.co/vTOL… | |
| 07 Nov 2017 | Social | RT @DrPetryna: #2453 #acr17 no difference in disease activity&PRO with ADA after MTX d/c at 6mo:LDA 42%ADAvs40%ADA+MTX @RheumNow https://t.… | |
| 06 Nov 2017 | Social | RT @uptoTate: Anti-TNF drugs could be safe following paternal exposure in pregnancy outcomes. #ACR17 @RheumNow #1312 https://t.co/G4s9zyOhoY | |
| 06 Nov 2017 | Social | RT @japaoli19: Crib study shows no detectable levels of CZP on infants umbilical cords #ACR17 @RheumNow https://t.co/7C1ctxv76c | |
| 04 Nov 2017 | Social | RT @KDAO2011: Dr L Gensler #ACR17: tobacco use decrease efficacy of TNF inhibitors | |
| 04 Nov 2017 | Social | RT @psufka: @_connectedcare My approach: If primary nonresponse to TNFi -> IL-17. If secondary nonresponse to TNFi -> 2nd TNFi #ACR17 |
